I would work in front of the PDUFA date. The April 11's probably. Should this be rejected yet again. you might well own some fine $1.25 MNKD stock.
By all means buy away! Far be it from me to suggest a little safety in biotech might be a good thing.
You should probably mortgage that trailer and buy another 12 shares.... on margin.
sell April 4th puts. If your real cautious sell the $4.00's and depending on your optimism go up from there.
You will still have a little wiggle room between the 4th and the fifteenth should you need it, and a modest margin of safety..
Sir you really need to buy a good short term municipal bond. It does not appear your cut out for biotech.
Do you know what an index fund is ? Vanguard has little to no interest in MNKD's fate or prospects. Their share holdings will rise or fall on based on the index's formula for MNKD's percentage of inclusion. No recommendation, just math.
with about 400 million shares to be outstanding, the next split might well be a one for two reverse split and should their be a third CRL it would likely be a one for fifteen.
How "rocky" will the ride get if along about early to mid April the PDUFA date gets pushed back a couple of weeks ? " Deja vu all over again." That might apply a little stress!
Only a passing thought.
given current pricing -- no advantage and a slight loss of liquidity.
The terms are 1 and 2/3 warrants plus $2.40 will exchange (buy) for one share of MNKD.
ie.- each warrant is 60 % of a share Above $2.40. expire Feb. 2016.
Only after approval would it have any value and then likely only 0-5% of capitalization. It would be several years before Technosphere would generate any revenue and other venues either exist or will be developed.
Inhaled medication is hardly new.